Ann: Clinical Update on IHL-42X for Obstructive Sleep Apnoea, page-144

First 144 Last

Share
Profile

Follow
MrFantastic

2,855 Posts.

1250

11/07/20

21:14

Post #: 45802171
Share

Originally posted by Exalted: ↑

On stocks that run like ESK/ATH tape reading is probably the most valuable skill to have...

Charting takes a backseat on the day of the mega pump itself. One minute chart would help and being able to tape read.

Anyways, that's all speculation and IHL probably wont get that kind of treatment unless the market gods will it so.

In the short term we have lots to look forward to!

Next week should come Stage 1 ARDS results, would be huge for the credibility of the BOD and IHL.
The BOD should also provide us guidance on when Stage 2 of the ARDS trial will commence.

On or before July 31st, Q2 Quarterly should come out. I'd be eyeing the costs of that one. I also suspect due to the amount of oppie conversions including Sud's $480K conversion could result in IHL having a positive quarter. I will also be looking at the other quarterlies of our peers, in particular AGH. Guidance for Q3 sales (right now) should also be in the quarterly and as per the Ann of Record Sales momentum is expected to continue into Q3.

By August 5 Ethics for OSA Phase 2B should be fully submitted to the Alfred Ethics Committee and that should pass quickly.
Commencement of the OSA Trial should probably happen shortly after! We know that IHL has sourced the patients already as per previous announcements... And as per ANZCTR its 30 patients, and should last 5 weeks. That could be updated and we will need new guidance to see.

It's also possible we see TBI Animal Trials to be commenced this quarter as well. Unfortunately the human trials for that will likely be on hold as long as the MMA has been affected by COVID.

Not to mention the possibilities of a Company Preso, New Website, Roadshow etc. Excited!

Expand

Fantastic outline E! Wish you were on the BOD! lol

IHL Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

1 Great analysis

Reply

Top Stories

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

GRX

GreenX picks up prospective copper project in Germany

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA